Arteriovenous fistulas are believed to be superior to grafts for vascular access in hemodialysis patients, but it is unclear whether this holds true in patients with a previous fistula failure.
Sportschosun on MSN3 天
Professor Park Hoon-seok's research team at Seoul St. Mary's Hospital won the best ...A research team led by Professor Park Hoon-seok of Nephrology at Catholic University of Korea's Seoul St. Mary's Hospital and ...
Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was ...
Hemodialysis (HD) is a life-saving treatment for more than 1,700,000 patients with chronic kidney disease (CKD) stage V. Every year the HD population becomes increasingly older (average age: 75 ...
A recent study from National Taiwan University Hospital shows that apixaban, a blood-thinning medication, can help prevent ...
At 6 months, the WRAPSODY CIE achieved 89.8% and 72.6% target lesion primary patency and access circuit primary patency, respectively.At 12 months, the WRAPSODY CIE achieved 70.1% and 58.1% target ...
Systems announced that the six-month results from the randomized arm of the WRAPSODY Arteriovenous Access Efficacy trial ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果